| Literature DB >> 36199032 |
Nadine Yossa1, Rebecca Bell2, Sandra Tallent2, Eric Brown2, Rachel Binet2, Thomas Hammack2.
Abstract
BACKGROUND: The Bacillus cereus group, also known as B. cereus sensu lato (s.l.) contains ubiquitous spore-forming bacteria found in the environment including strains from the B. cereus sensu stricto (s.s.) species. They occur naturally in a wide range of raw materials and in consumer products. Characterizing isolates that have survived in consumer products allows us to better understand the mechanisms that permit spores to persist and potentially cause illness. Here we characterize the draft genome sequence of B. cereus s. s. 3A-ES, originally isolated from eye shadow and since investigated in several cosmetic studies and compared it to other top ten published complete genome sequences of B. cereus s.l. members.Entities:
Keywords: Bacillus cereus; Complete genome sequence; Cosmetics; Resistant genes; Virulence factors
Mesh:
Substances:
Year: 2022 PMID: 36199032 PMCID: PMC9533521 DOI: 10.1186/s12866-022-02652-5
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 4.465
Assembly and annotation statistics of B. cereus s.s. 3A ES
| Genome | |
|---|---|
| Coarse consistency (%) | 99.8 |
| Fine consistency (%) | 98.2 |
| Completeness (%) | 100 |
| Contamination (%) | 0 |
| Contig count | 90 |
| GC Content | 34.9880 |
| DNA size (bp) | 5,335,727 |
| Contigs N50 (bp) | 192,359 |
| Contigs L50 | 9 |
| Overpresent Roles | 17 |
| Underpresent Roles | 7 |
| Predicted Roles | 1370 |
| Completeness Roles | 43 |
| Total Distinct Roles | 3308 |
| Protein-Encoding Genes with Functional Assignment | 3408 |
| Protein-Encoding Genes without Functional Assignment | 2101 |
| % Protein-Encoding Feature Coverage | 103.25 |
| % Features that are Hypothetical | 38.14 |
| % Features that are in Local Protein Families | 96.57 |
| Number of subsytems | 287 |
| Number of coding sequences (CDS) | 5509 |
| Number of tRNA | 60 |
| Number of rRNA | 4 |
| Plasmid | 0 |
Fig. 1Circular display of the distribution of the draft genome annotations in B. cereus s.s. 3A ES. From the outer to the inner rings, this display includes: the contigs, coding sequences (CDS) on the forward (FWD) strand, CDS on the reverse (REV) strand, RNA genes, CDS with homology to known antimicrobial resistance genes, CDS with homology to known virulence factors, GC content and GC skew. The colors of the CDS on the forward and reverse strand should have indicated to which subsystem (see Fig. 2) these genes belong
Fig. 2Overview of subsystems within the B. cereus s.s. 3A-ES genome
Genes relevant to risk assessment in B. cereus s.s. 3A-ES
| Gene category | Genes | Source |
|---|---|---|
| Virulence Factor | 12 | Victors |
| Virulence Factor | 9 | VFDB |
| Transporter | 49 | TCDB |
| Drug Target | 27 | Drug Bank |
| Antibiotic Resistance | 54 | PATRIC |
| Antibiotic Resistance | 7 | CARD |
| Antibiotic Resistance | 5 | NDARO |
VFDB virulence factor database, TCDB transporter classification database, PATRIC PAThosystems Resource Integration Center, CARD, comprehensive antibiotic resistance database, NDARO: National Data of Antibiotic Resistant Organisms
Source and virulence genes found in B. cereus s.s. 3A-ES
| Source ID | Source Organism | Gene | Product | Subject Coverage | Query Coverage | Identity | E-value |
|---|---|---|---|---|---|---|---|
| VFG016223 | BC ATCC 10987 | Cytolytic pore-forming protein = > Cytotoxin K | 100 | 100 | 97 | 1e-192 | |
| VFG016270 | BC ATCC 10987 | Non-hemolytic enterotoxin A | 100 | 100 | 96 | 1e-209 | |
| VFG016338 | BA str. Sterne | Immune inhibitor A, metalloprotease (EC 3.4.24.-) | 100 | 100 | 95 | 0.0 | |
| VFG016263 | BC ATCC 14579 | Hypothetical protein | 100 | 100 | 96 | 1e-238 | |
| VFG016278 | BC ATCC 10987 | Non-hemolytic enterotoxin lytic component L1 | 100 | 100 | 99 | 1e-225 | |
| VFG016254 | BC ATCC 14579 | Hypothetical protein | 100 | 100 | 98 | 1e-269 | |
| VFG016216 | BA str. Sterne | Thiol-activated cytolysin | 100 | 100 | 96 | 1e-289 | |
| VFG016260 | BC ATCC 14579 | Hypothetical protein | 100 | 100 | 99 | 1e-231 | |
| Drugbank | BC | Broad-substrate range phospholipase C (EC 3.1.4.3) | 100 | 100 | 95 | 1e-164 1e-164 | |
| VFG016286 | BC ATCC 10987 | Enterotoxin C | 100 | 100 | 94 | 1e-194 |
Stress response defense virulence in B. cereus s.s. 3A ES
| Subclass | Subsystem Name | Gene Count | Role Count | Active |
|---|---|---|---|---|
| Toxins and superantigens | Pore-forming cytolytic toxins | 1 | 1 | active |
| Stress Response: Osmotic stress | Choline uptake and conversion to betaine clusters | 8 | 5 | active |
| Stress Response: Osmotic stress | Osmoregulation | 2 | 2 | active |
| Stress Response: Heat/cold shock | Heat shock dnaK gene cluster extended | 16 | 16 | active |
| Stress Response: Heat/cold shock | Cold shock proteins of CSP family | 6 | 2 | active |
| Stress Response: Electrophile toxicity | Bacillithiol synthesis | 4 | 3 | active |
| Stress Response | Cluster containing Glutathione synthetase | 2 | 2 | likely |
| Stress Response | Glutathione: Non-redox reactions | 4 | 2 | likely |
| Stress Response | CoA disulfide thiol-disulfide redox system | 1 | 2 | active |
| Stress Response | Protection from Reactive Oxygen Species | 9 | 7 | active |
| Stress Response | Universal stress protein family | 2 | 1 | active |
| Stress Response | Repair of Iron Centers | 1 | 1 | active |
| Stress Response | Glutathione: Redox cycle | 1 | 1 | active |
| Stress Response | Stress proteins YciF, YciE | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Aminoglycoside modifying enzymes: O-nucleotidyltransferases | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Fosfomycin resistance | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Resistance to Daptomycin | 14 | 7 | active |
| Resistance to antibiotics and toxic compounds | Resistance to Vancomycin and Teicoplanin | 7 | 3 | likely |
| Resistance to antibiotics and toxic compounds | Beta-lactamases Ambler class A | 2 | 1 | active |
| Resistance to antibiotics and toxic compounds | Antibiotic targets in protein synthesis | 9 | 8 | active |
| Resistance to antibiotics and toxic compounds | Antibiotic targets in metabolic pathways | 7 | 5 | active |
| Resistance to antibiotics and toxic compounds | Antibiotic targets in DNA processing | 4 | 4 | active |
| Resistance to antibiotics and toxic compounds | VraTSR and LiaFSR three-component regulatory systems | 5 | 5 | active |
| Resistance to antibiotics and toxic compounds | Copper homeostasis: copper tolerance | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Fusidic acid resistance | 2 | 2 | likely |
| Resistance to antibiotics and toxic compounds | Macrolides, lincosamides, streptogramins, ketolides, oxazolidinones (MLSKO) resistance: enzymatic degradation | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Bacitracin resistance | 3 | 3 | active |
| Resistance to antibiotics and toxic compounds | Antibiotic targets in cell wall biosynthesis | 6 | 3 | active |
| Resistance to antibiotics and toxic compounds | Vancomycin resistance, D-Ala-D-Ala dipeptidases and carboxypeptidases | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Arsenic resistance | 7 | 5 | active |
| Resistance to antibiotics and toxic compounds | Antibiotic targets in transcription | 3 | 3 | active |
| Resistance to antibiotics and toxic compounds | Aminoglycoside modifying enzymes: N-acetyltransferases | 1 | 1 | likely |
| Resistance to antibiotics and toxic compounds | Beta-lactamases Ambler class B | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Resistance to Triclosan | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Resistance to chromium compounds | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Mupirocin resistance | 2 | 1 | likely |
| Resistance to antibiotics and toxic compounds | Chloramphenicol resistance | 1 | 1 | active |
| Resistance to antibiotics and toxic compounds | Tetracycline resistance, all mechanisms | 2 | 2 | active |
| Resistance to antibiotics and toxic compounds | Macrolides, lincosamides, streptogramins, ketolides, oxazolidinones (MLSKO) resistance: ribosomal protection | 1 | 1 | active |
| Invasion and intracellular resistance | Listeria surface proteins: Internalin-like proteins | 3 | 1 | active |
| Host–pathogen interactions | Hydrolysis of sphingomyelin | 2 | 2 | active |
| Hfl operon | 5 | 5 | active |
Antimicrobial resistance genes found in B. cereus s.s. 3A ES
| AMR Mechanism | Genes |
|---|---|
| Antibiotic inactivation enzyme | BcII family, CatA15/A16 family, FosB |
| Antibiotic target in susceptible species | Alr, Ddl, dxr, EF-G, EF-Tu, folA, Dfr, folP, gyrA, gyrB, inhA, fabI, Iso-tRNA, kasA, MurA, rho, rpoB, rpoC, S10p, S12p |
| Antibiotic target protection protein | BcrC, Lsa(B) |
| Efflux pump conferring antibiotic resistance | BcrA, BcrB, YkkCD |
| Gene conferring resistance via absence | gidB |
| Protein altering cell wall charge conferring antibiotic resistance | GdpD, MprF, PgsA |
| Protein altering cell wall structure conferring antibiotic resistance | VanXY-unclassified |
| Regulator modulating expression of antibiotic resistance genes | LiaF, LiaR, LiaS, VanB-type, VanF/M-type |
Fig. 3Phylogenetic tree constructed based on the homologous genomes of NCBI’ s high quality and of PATRIC’ reference and representative genomes. B. cereus s.s